Abstract
杨智荣,孙凤,詹思延.偏倚风险评估系列:(二)平行设计随机对照试验偏倚评估工具2.0介绍[J].Chinese journal of Epidemiology,2017,38(9):1285-1291
偏倚风险评估系列:(二)平行设计随机对照试验偏倚评估工具2.0介绍
Risk on bias assessment:(2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)
Received:March 10, 2017  
DOI:10.3760/cma.j.issn.0254-6450.2017.09.028
KeyWord: 偏倚风险  评估工具  随机对照试验  平行设计  系统综述
English Key Word: Risk of bias  Tool for assessment  Randomized controlled trial  Parallel design  Systematic review
FundProject:国家自然科学基金(71673003)
Author NameAffiliationE-mail
Yang Zhirong Primary Care Unit, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridgeshire CB1
8RN, UK 
 
Sun Feng Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
Center of Evidence-based Medicine and Clinical Research, Peking University, Beijing 100191, China 
sunfeng@bjmu.edu.cn 
Zhan Siyan Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
Center of Evidence-based Medicine and Clinical Research, Peking University, Beijing 100191, China 
 
Hits: 15899
Download times: 4575
Abstract:
      本文针对平行设计随机对照试验(RCT)Cochrane偏倚评估工具2.0版本(RoB2.0)的主要内容进行介绍,同时对RoB2.0与前一个版本RoB1.0的区别与联系进行阐述,并举例说明RoB2.0的使用方法和注意事项。RoB2.0内容丰富,覆盖全面,为RCT的证据整合与评价提供了更多的偏倚风险信息。RoB2.0仍处于开发与进一步完善中,使用者可持续关注其后续更新与进展。
English Abstract:
      This paper introduces the revised cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0), compates RoB2.0 and the previous version (RoB1.0). And illustrates the application of RoB2.0 for a published clinical trial. As a comprehensive tool, RoB2.0 provides more information on the risk of bias for evidence synthesis. RoB2.0 is still under development and it is suggested that the users should follow the updates of the developers in the future.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close